Source: International Congress 2016 – Orphan diseases II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maria Laura Alberti (Ciudadela, Argentina), Maria Laura Alberti, Francisco Paulin, Martin Eduardo Fernández, Fabián Matías Caro. Treatment response in hypersensitivity pneumonitis. Eur Respir J 2016; 48: Suppl. 60, 3919

Member's Comments

No comment yet.

Related content which might interest you: Effect of pirfenidone on IPF progression Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Rituximab for the treatment of chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 To treat or not to treat with corticosteroids radiation induced pneumonitis Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Influence of fungal colonization on 6-minute-walk test disance in patients with hypersensitivity pneumonitis Source: Annual Congress 2013 –Modern approach to various clinical settings Year: 2013 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum Source: International Congress 2014 – ILDs 2 Year: 2014 Chronic hypersensitivity pneumonitis: Is the interstitial pneumonias disease behavior classification suitable for outcome stratification? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Pulmonary function tests as predictors of mortality in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis Source: International Congress 2014 – ILDs 3 Year: 2014 Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Asbestos-related disorders (ARDs): Influence of pleural plaques and pulmonary fibrosis due to asbestos exposure on lung function decline (LFD) Source: International Congress 2014 – ILDs 5 Year: 2014 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Evaluation of romidepsin (FK228) as a potential therapy for idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Clinical experience with pirfenidone for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Hypoxic challenge testing in idiopathic pulmonary fibrosis Source: International Congress 2016 – Orphan diseases I Year: 2016 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014